Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events

Serum irisin levels in new-onset type 2 diabetes

(2013) Yeon-Kyung Choi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals

(2013) Hyun-Seuk Moon et al.   ENDOCRINE REVIEWS

Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans

(2013) Maria T Vamvini et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome

(2013) Kyung Hee Park et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

(2013) José María Moreno-Navarrete et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lower circulating irisin is associated with type 2 diabetes mellitus

(2013) Jian-Jun Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass

(2013) Andrew G. Swick et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats

(2013) Michael D. Roberts et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Irisin: A renaissance in metabolism?

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Exercise training does not increase muscle FNDC5 protein or mRNA expression in pigs

(2013) John N. Fain et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Irisin in humans: recent advances and questions for future research

(2013) Pontus A. Boström et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo

(2013) Ioanna Gouni-Berthold et al.   PLoS One

Expression of the Irisin Precursor FNDC5 in Skeletal Muscle Correlates With Aerobic Exercise Performance in Patients With Heart Failure

(2012) Stewart H. Lecker et al.   Circulation-Heart Failure

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

(2012) Lokpal S. Bhatia et al.   EUROPEAN HEART JOURNAL

Brown adipose tissue regulates glucose homeostasis and insulin sensitivity

(2012) Kristin I. Stanford et al.   JOURNAL OF CLINICAL INVESTIGATION

FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise

(2012) Joo Young Huh et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Is irisin a human exercise gene?

(2012) James A. Timmons et al.   NATURE

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

(2012) Pontus Boström et al.   NATURE

A Muscular Twist on the Fate of Fat

(2012) Bente Klarlund Pedersen   NEW ENGLAND JOURNAL OF MEDICINE

Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index

(2012) Andreas Stengel et al.   PEPTIDES

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention

(2009) J. M. de la Hera et al.   EUROPEAN HEART JOURNAL